Sex differences in utilization and outcomes of catheter-directed thrombolysis in patients with proximal lower extremity deep venous thrombosis - Insights from the Nationwide Inpatient Sample

Vasc Med. 2017 Apr;22(2):128-134. doi: 10.1177/1358863X17694091. Epub 2017 Mar 17.

Abstract

Catheter-directed thrombolysis (CDT) is being increasingly used for the treatment of proximal lower extremity (LE) deep venous thrombosis (DVT). However, sex differences in utilization and safety outcomes of CDT in these patients are unknown. The Nationwide Inpatient Sample (NIS) database was used to identify all patients with a principal discharge diagnosis of proximal LE or caval DVT who underwent CDT between January 2005 and December 2011 in the United States. We evaluated the comparative safety outcomes of CDT among a propensity-matched group of 1731 men versus 1731 women. Among 108,243 patients with proximal LE or caval DVT, 4826 patients (4.5%) underwent CDT. Overall, women underwent CDT less often compared to men (4.1% vs 4.9%, p<0.01, respectively). The rates of CDT increased between 2005 and 2011 for both women (2.1% to 5.9%, p<0.01) and men (2.5% to 7.5%, p<0.01). There was no significant difference in in-hospital mortality (1.2% vs 1.3%, p=0.76). Women were noted to have higher rates of blood transfusions (11.7% vs 8.8%, p<0.01), but lower rates of intracranial hemorrhage (0.5% vs 1.2%, p=0.03) and gastrointestinal bleeding (0.9% vs 2.2%, p<0.01) compared with men. Women were more likely to undergo inferior vena cava filter placement (37.0% vs 32.1%, p<0.01). In this large nationwide cohort, women with proximal DVT were less likely to receive CDT compared to men. Although mortality rates were similar, women were noted to have higher blood transfusion rates while men had more episodes of intracranial and gastrointestinal bleeding.

Keywords: administrative data; deep vein thrombosis; lower extremity; safety outcomes; sex differences; thrombolytic therapy.

Publication types

  • Comparative Study
  • Observational Study

MeSH terms

  • Administration, Intravenous
  • Adult
  • Aged
  • Angioplasty / instrumentation
  • Angioplasty / statistics & numerical data
  • Blood Transfusion / statistics & numerical data
  • Catheterization, Peripheral / adverse effects
  • Catheterization, Peripheral / mortality
  • Catheterization, Peripheral / statistics & numerical data*
  • Databases, Factual
  • Drug Utilization Review
  • Female
  • Fibrinolytic Agents / administration & dosage*
  • Fibrinolytic Agents / adverse effects
  • Gastrointestinal Hemorrhage / etiology
  • Gastrointestinal Hemorrhage / therapy
  • Health Resources / statistics & numerical data*
  • Healthcare Disparities*
  • Hospital Mortality
  • Humans
  • Intracranial Hemorrhages / etiology
  • Intracranial Hemorrhages / therapy
  • Logistic Models
  • Lower Extremity / blood supply*
  • Male
  • Middle Aged
  • Multivariate Analysis
  • Odds Ratio
  • Propensity Score
  • Risk Factors
  • Sex Factors
  • Stents / statistics & numerical data
  • Thrombolytic Therapy / adverse effects
  • Thrombolytic Therapy / instrumentation
  • Thrombolytic Therapy / mortality
  • Thrombolytic Therapy / statistics & numerical data*
  • Time Factors
  • Treatment Outcome
  • United States
  • Vena Cava Filters / statistics & numerical data
  • Venous Thrombosis / diagnosis
  • Venous Thrombosis / drug therapy*
  • Venous Thrombosis / mortality

Substances

  • Fibrinolytic Agents